ID   Mel-2a
AC   CVCL_A759
SY   Mel-2A; Mel 2a; Mel 2A; Mel2a; Mel2A
DR   Cosmic; 1181747
DR   Cosmic; 1221592
DR   Wikidata; Q54905071
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=3485457;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.1007/BF00199208;
RA   Bruggen J., Sorg C., Macher E.;
RT   "Membrane associated antigens of human malignant melanoma V:
RT   Serological typing of cell lines using antisera from nonhuman
RT   primates.";
RL   Cancer Immunol. Immunother. 5:53-62(1978).
//
RX   DOI=10.1007/BF00205883;
RA   Bruggen J., Macher E., Sorg C.;
RT   "Expression of surface antigens and its relation to parameters of
RT   malignancy in human malignant melanoma.";
RL   Cancer Immunol. Immunother. 10:121-127(1981).
//
RX   PubMed=3485457; DOI=10.1182/blood.V67.4.1139.1139;
RA   van Leeuwen A., Schrier P.I., Giphart M.J., Noordermeer I.A.,
RA   Ruiter D.J., Rubinstein P., van Rood J.J.;
RT   "TCA: a polymorphic genetic marker in leukemias and melanoma cell
RT   lines.";
RL   Blood 67:1139-1142(1986).
//